The present invention is directed to novel compounds and pharmaceutical compositions that inhibit the binding of the SDF-1 chemokine to the chemokine receptor CXCR4 and/or the binding of the SDF-1 or I-TAC chemokines to the chemokine receptor CCXCKR2 (CXCR7). These compounds are useful in preventing tumor cell proliferation, tumor formation, metastasis, inflammatory diseases, treatment of HIV infectivity, treatment of stem cell differentiation and mobilization disorders, and ocular disorders.

 
Web www.patentalert.com

< Methods for inhibition of membrane-fusion-associated events, including Hepatitis B virus transmission

> Suppressors of CpG oligonucleotides and methods of use

> Compositions for use in recombinational cloning of nucleic acids

~ 00584